1. |
Treating extrapyramidal symptoms correctly in the elderly |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1140KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
2. |
Colorectal cancer: old challenges, new issues |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 3-4
Julie Daniels,
Preview
|
PDF (2158KB)
|
|
摘要:
Although modulated fluorouracil is still the mainstay of antineoplastic treatment for colorectal cancer, it is now joined by newer therapeutic approaches, including the use of topoisomerase I inhibitors and specific thymidylate synthase inhibitors. Recent phase III data on the thymidylate synthase inhibitor Tomudex® [ZD-1694] have shown that the efficacy of this agent is comparable to that of the Mayo regimen (fluorouracil + calcium folinate). The results of this study, and other news relating to improved therapy for colorectal cancer, were presented at a Zenecasponsored symposium held at the 8th European Cancer Conference [ECCO 8;Paris, France; November 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
3. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 5-5
&NA;,
Preview
|
PDF (1025KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
4. |
Consider QOL in survivors of life-threatening arrhythmias |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1080KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
5. |
Ularitide produces dose-dependent bronchodilation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 7-7
&NA;,
Preview
|
PDF (993KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
6. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1058KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
7. |
PAF antagonists: new data show positive effect in asthma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 9-10
Tamara Schwarz,
Preview
|
PDF (2150KB)
|
|
摘要:
In contrast to the disappointing results seen in early trials of platelet-activating factor (PAF) antagonists in patients with asthma, a recent study has indicated that Boehringer Ingelheim's apafant [WEB-2086] may provide therapeutic benefit. It is possible that previous conclusions regarding PAF-antagonist activity were based on insufficient data. Now, researchers have been provided with a new incentive to continue the development of these agents as an alternative treatment for patients with asthma. The results of the apafant trial were presented at the 5th International Congress on Platelet-Activating Factor and Related Lipid Mediators [Berlin, Germany; September 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
8. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 10-10
&NA;,
Preview
|
PDF (1061KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
9. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 11-11
&NA;,
Preview
|
PDF (1045KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
10. |
Estrogen + naproxen improves urge incontinence |
|
Inpharma Weekly,
Volume &NA;,
Issue 1013,
1995,
Page 12-12
&NA;,
Preview
|
PDF (1081KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|